Taken together, the positive correlation of ERG-induced mesenchymal-like gene signature in leukemia with solid tumor prostate cancer tissues demonstrate that an ERG-specific gene signature is induced, which is independent of disease origin, and may provide sensitive molecular targets of prognostic value, thereby aiding in predicting the outcome or response to therapy. The gene discussed is ERG; the disease is prostate carcinoma.